[On Demand]
Novai is a British biotechnology start-up, developing and commercialising DARC (Detection of Apoptosing Retinal Cells), an exploratory retinal biomarker for use in Age-related Macular Degeneration (AMD) & glaucoma clinical studies. DARC combines an innovative patented biologic with a state of the art AI algorithm and uses standard imaging equipment to identify cellular level disease activity.